• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mesenchymal stromal cell infusion modulates systemic immunological responses in stable COPD patients: a phase I pilot study.

作者信息

Armitage Jesse, Tan Dino B A, Troedson Russel, Young Paul, Lam Kay-Vin, Shaw Kathryn, Sturm Marian, Weiss Daniel J, Moodley Yuben P

机构信息

Centre for Respiratory Health, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.

Stem Cell Unit, Institute of Respiratory Health, Perth, Australia.

出版信息

Eur Respir J. 2018 Mar 1;51(3). doi: 10.1183/13993003.02369-2017. Print 2018 Mar.

DOI:10.1183/13993003.02369-2017
PMID:29348155
Abstract
摘要

相似文献

1
Mesenchymal stromal cell infusion modulates systemic immunological responses in stable COPD patients: a phase I pilot study.间充质基质细胞输注对稳定期慢性阻塞性肺疾病患者全身免疫反应的调节作用：一项I期试点研究。
Eur Respir J. 2018 Mar 1;51(3). doi: 10.1183/13993003.02369-2017. Print 2018 Mar.
2
Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study.异体脐带间充质干细胞移植治疗慢性阻塞性肺疾病的临床研究。
Stem Cell Res Ther. 2020 Feb 13;11(1):60. doi: 10.1186/s13287-020-1583-4.
3
Mesenchymal stromal cells: a novel therapy for the treatment of chronic obstructive pulmonary disease?间质基质细胞：一种治疗慢性阻塞性肺疾病的新疗法？
Thorax. 2018 Jun;73(6):565-574. doi: 10.1136/thoraxjnl-2017-210672. Epub 2018 Apr 13.
4
Autologous Infusion of Bone Marrow and Mesenchymal Stromal Cells in Patients with Chronic Obstructive Pulmonary Disease: Phase I Randomized Clinical Trial.自体骨髓和间充质基质细胞输注治疗慢性阻塞性肺疾病患者：I 期随机临床试验。
Int J Chron Obstruct Pulmon Dis. 2021 Dec 29;16:3561-3574. doi: 10.2147/COPD.S332613. eCollection 2021.
5
Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.慢性阻塞性肺疾病患者在疾病稳定期长期被流感嗜血杆菌定植，其气道炎症会加重。
Int J Chron Obstruct Pulmon Dis. 2015 May 4;10:881-9. doi: 10.2147/COPD.S78748. eCollection 2015.
6
The effect of comorbidities on COPD assessment: a pilot study.合并症对慢性阻塞性肺疾病评估的影响：一项试点研究。
Int J Chron Obstruct Pulmon Dis. 2015 Feb 25;10:429-38. doi: 10.2147/COPD.S76124. eCollection 2015.
7
Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease.核因子红细胞2相关因子2在慢性阻塞性肺疾病患者中的临床意义
Korean J Intern Med. 2018 Jul;33(4):745-752. doi: 10.3904/kjim.2017.030. Epub 2018 Mar 13.
8
Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.血清TRAIL和DR5水平升高与稳定期慢性阻塞性肺疾病（COPD）患者的肺功能及炎症相关。
Int J Chron Obstruct Pulmon Dis. 2015 Nov 6;10:2405-12. doi: 10.2147/COPD.S92260. eCollection 2015.
9
Mesenchymal stem cells.间充质干细胞。
Thorax. 2012 Jun;67(6):565-6. doi: 10.1136/thoraxjnl-2012-201923. Epub 2012 May 3.
10
Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography.定量正电子发射断层扫描评估肺气肿中的肺中性粒细胞炎症。
Am J Respir Crit Care Med. 2012 Dec 1;186(11):1125-32. doi: 10.1164/rccm.201201-0051OC. Epub 2012 Jul 26.

引用本文的文献

1
Human macrophage migration inhibitory factor potentiates mesenchymal stromal cell efficacy in a clinically relevant model of allergic asthma.人巨噬细胞移动抑制因子增强间充质基质细胞在变应性哮喘临床相关模型中的疗效。
Mol Ther. 2023 Nov 1;31(11):3243-3258. doi: 10.1016/j.ymthe.2023.09.013. Epub 2023 Sep 20.
2
Regenerative and translational medicine in COPD: hype and hope.COPD 中的再生和转化医学：炒作与希望。
Eur Respir Rev. 2023 Jul 26;32(169). doi: 10.1183/16000617.0223-2022. Print 2023 Sep 30.
3
Mesenchymal Stem Cells from COPD Patients Are Capable of Restoring Elastase-Induced Emphysema in a Murine Experimental Model.
COPD 患者来源的间充质干细胞能够恢复弹性蛋白酶诱导的小鼠实验性肺气肿。
Int J Mol Sci. 2023 Mar 18;24(6):5813. doi: 10.3390/ijms24065813.
4
What is the need and why is it time for innovative models for understanding lung repair and regeneration?理解肺修复和再生的创新模式的需求是什么，为什么现在是时候了？
Front Pharmacol. 2023 Feb 13;14:1130074. doi: 10.3389/fphar.2023.1130074. eCollection 2023.
5
Stem cell-based therapy for human diseases.基于干细胞的人类疾病治疗方法。
Signal Transduct Target Ther. 2022 Aug 6;7(1):272. doi: 10.1038/s41392-022-01134-4.
6
Biologics in COVID-19 So Far: Systematic Review.截至目前COVID-19治疗中生物制剂的应用：系统评价
Pharmaceuticals (Basel). 2022 Jun 23;15(7):783. doi: 10.3390/ph15070783.
7
Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment.间充质干细胞：在 2019 冠状病毒病治疗中崭露头角。
Cytotherapy. 2022 Aug;24(8):755-766. doi: 10.1016/j.jcyt.2020.07.002. Epub 2020 Jul 15.
8
Impaired Alveolar Re-Epithelialization in Pulmonary Emphysema.肺气肿中的肺泡再上皮化受损。
Cells. 2022 Jun 28;11(13):2055. doi: 10.3390/cells11132055.
9
Chronic obstructive pulmonary disease and asthma: mesenchymal stem cells and their extracellular vesicles as potential therapeutic tools.慢性阻塞性肺疾病和哮喘：间充质干细胞及其细胞外囊泡作为潜在的治疗工具。
Stem Cell Res Ther. 2022 Jun 20;13(1):262. doi: 10.1186/s13287-022-02938-5.
10
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis.基于干细胞的再生疗法和 COPD 衍生产品：系统评价和荟萃分析。
Cells. 2022 May 30;11(11):1797. doi: 10.3390/cells11111797.